Team Spirit Guides Gandara in Personalizing Care

Katie Kosko
Published: Saturday, Jun 30, 2018
David R. Gandara, MD
David R. Gandara, MD
Each morning, David R. Gandara, MD, wakes up energized to spend another day as an oncologist in lung cancer practice and research, a field in which advances have been more rapid than anything previously seen in oncology.

Growing up in Tyler, Texas—a town 100 miles east of Dallas—Gandara realized early on that his dual calling was in medicine and in writing. His current academic position at UC Davis gives him the opportunity to use his communication skills to the fullest. “I thought medicine would be a good way to be able to do that. I always envisioned myself being in academic medicine, where teaching is an integral part of what I do.”

The Road to Oncology

Gandara earned his undergraduate degree from The University of Texas at Austin and went on to attend medical school at The University of Texas Medical Branch in Galveston, where he graduated with honors. At night, he worked as an emergency crossmatching technician for blood transfusions.

The biggest change in Gandara’s career came after his appointment as chair of the SWOG Lung Cancer Committee. “It allowed me to express myself,” he said. “I was relatively junior when that happened, and it allowed me to, over a period of 15 years, grow my own career and mentor a lot of other people and be associated with many important projects in lung cancer.” Gandara is multiskilled and finds himself wearing many hats. He spends his time teaching, conducting clinical research, designing clinical trials, doing administrative work, and seeing patients. “I take care of all the components of an academic career,” Gandara said.
His research is focused on the development of new anticancer agents, preclinical modeling, and clinical research, aided by Gandara’s leadership of multidisciplinary teams. His recent work includes phase I molecular and clinical pharmacology trials, early therapeutics trials with phase II emphasis, and discovery and identification of blood biomarkers for early detection of lung cancer. In addition, Gandara has been instrumental in teaching others about multimodality therapy, such as how to integrate radiation with chemotherapy and surgery.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in TrialsJun 29, 20192.5
Community Practice Connections™: 3rd Annual School of Gastrointestinal Oncology® (SOGO®)Jun 29, 20191.5
Publication Bottom Border
Border Publication
x